Shubha Singhal
Impact in
-
- Curcumin's Biomedical Applications
Papers in
-
- Pharmaceutical studies and practices 2
- Surgery 2
- Co-authors
- Rima Shah (8 shared papers)Siddhartha Dutta (8 shared papers)Bhupinder Singh Kalra (2 shared papers)Mainul Haque (3 shared papers)Sumit Bansal (4 shared papers)Susmita Sinha (1 shared paper)Shalini Chawla (2 shared papers)Rohit Chawla (1 shared paper)
- Journals
- Expert Opinion on Drug Safety (2 papers)European Journal of Pediatrics (1 paper)Trials (1 paper)International Journal of Microbiology Research (1 paper)Drug Design Development and Therapy (1 paper)
- Partner nations
- IndiaMalaysiaBangladesh
In The Last Decade
Shubha Singhal
17 papers receiving 227 citations
Shubha Singhal's Hit Papers
Peers
Comparison fields: 5 of 86
- Health Informatics 7
- Molecular Medicine 21
- Applied Microbiology and Biotechnology 4
- Endocrinology, Diabetes and Metabolism 26
- Library and Information Sciences 2
Countries citing papers authored by Shubha Singhal
This map shows the geographic impact of Shubha Singhal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shubha Singhal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shubha Singhal more than expected).
Fields of papers citing papers by Shubha Singhal
This network shows the impact of papers produced by Shubha Singhal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shubha Singhal. The network helps show where Shubha Singhal may publish in the future.
Co-authors
The 18 scholars most cited alongside Shubha Singhal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes Hit paper breakdown → | 2023 | 122 |
| 2 | 2021 | 35 | |
| 3 | 2021 | 28 | |
| 4 | 2018 | 7 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2019 | 4 | |
| 10 | 2023 | 3 | |
| 11 | 2018 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2015 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2026 | 0 |
About Shubha Singhal
Shubha Singhal is a scholar working on Pediatrics, Perinatology and Child Health, Surgery, Public Health, Environmental and Occupational Health, Infectious Diseases and Molecular Biology, having authored 20 papers that have together received 233 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Pregnancy and Medication Impact (1 paper), Antibiotic Use and Resistance (1 paper), Academic integrity and plagiarism (1 paper), Pharmaceutical industry and healthcare (1 paper), Immunotherapy and Immune Responses (1 paper) and Curcumin's Biomedical Applications (1 paper). The work is most often cited by research in Health Informatics (7 citations), Molecular Medicine (21 citations), Applied Microbiology and Biotechnology (4 citations), Endocrinology, Diabetes and Metabolism (26 citations) and Library and Information Sciences (2 citations). Shubha Singhal has collaborated with scholars based in India, Malaysia and Bangladesh. Frequent co-authors include Rima Shah, Siddhartha Dutta, Bhupinder Singh Kalra, Mainul Haque, Sumit Bansal, Susmita Sinha, Shalini Chawla, Rohit Chawla, Anil Dhal and Surjit Singh. Their work appears in journals such as Expert Opinion on Drug Safety, European Journal of Pediatrics, Trials, International Journal of Microbiology Research and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.